Publication: The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients.
dc.contributor.author | Garzotto, F | |
dc.contributor.author | Ostermann, M | |
dc.contributor.author | Martín-Langerwerf, D | |
dc.contributor.author | Sánchez-Sánchez, M | |
dc.contributor.author | Teng, J | |
dc.contributor.author | Robert, R | |
dc.contributor.author | Marinho, A | |
dc.contributor.author | Herrera-Gutierrez, M E | |
dc.contributor.author | Mao, H J | |
dc.contributor.author | Benavente, D | |
dc.contributor.author | Kipnis, E | |
dc.contributor.author | Lorenzin, A | |
dc.contributor.author | Marcelli, D | |
dc.contributor.author | Tetta, C | |
dc.contributor.author | Ronco, C | |
dc.contributor.authoraffiliation | [Garzotto,F; Ronco,C] Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy. [Garzotto,F; Lorenzin,A; Ronco,C] International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Vicenza, Italy. [Ostermann,M] Department of Critical Care, King’s College London, Guy’s and St Thomas’ Hospital, UK. [Martín-Langerwerf,D] Servicio de Medicina Intensiva, Hospital Universitario del Vinalopo, Elche, Spain. [Sánchez-Sánchez,M] Intensive Care, Hospital Universitario La Paz/Carlos III. IdiPAZ, Madrid, Spain. [Teng,J] Department of Nephrology, Shanghai Institute of Kidney and Dialysis, Shanghai Key Laboratory of Kidney and Blood Purification, Zhongshan Hospital, Fudan University, Shanghai, China. [Robert,R] Medical Intensive Care, University of Poitiers; CHU Poitiers, France. [Marinho,A] Intensive Care Service, St Antonio Hospital –Porto, Portugal. [Herrera-Gutierrez,ME] Intensive Care Unit, General University Hospital, Malaga, Spain. [Mao,HJ] Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China. [Benavente,D] Department of Nephrology, Clinica Las Condes, Estoril Santiago, Chile. [Kipnis,E] Department of Anesthesiology and Critical Care, University Hospital, Lille, France. [Marcelli,D; Tetta,C] Fresenius Medical Care, Bad Homburg, Germany. | es |
dc.contributor.group | The DoReMiFa study group | es |
dc.date.accessioned | 2016-09-06T11:40:28Z | |
dc.date.available | 2016-09-06T11:40:28Z | |
dc.date.issued | 2016-06-23 | |
dc.description | JOURNAL ARTICLE; | es |
dc.description.abstract | BACKGROUND The previously published "Dose Response Multicentre International Collaborative Initiative (DoReMi)" study concluded that the high mortality of critically ill patients with acute kidney injury (AKI) was unlikely to be related to an inadequate dose of renal replacement therapy (RRT) and other factors were contributing. This follow-up study aimed to investigate the impact of daily fluid balance and fluid accumulation on mortality of critically ill patients without AKI (N-AKI), with AKI (AKI) and with AKI on RRT (AKI-RRT) receiving an adequate dose of RRT. METHODS We prospectively enrolled all consecutive patients admitted to 21 intensive care units (ICUs) from nine countries and collected baseline characteristics, comorbidities, severity of illness, presence of sepsis, daily physiologic parameters and fluid intake-output, AKI stage, need for RRT and survival status. Daily fluid balance was computed and fluid overload (FO) was defined as percentage of admission body weight (BW). Maximum fluid overload (MFO) was the peak value of FO. RESULTS We analysed 1734 patients. A total of 991 (57 %) had N-AKI, 560 (32 %) had AKI but did not have RRT and 183 (11 %) had AKI-RRT. ICU mortality was 22.3 % in AKI patients and 5.6 % in those without AKI (p < 0.0001). Progressive fluid accumulation was seen in all three groups. Maximum fluid accumulation occurred on day 2 in N-AKI patients (2.8 % of BW), on day 3 in AKI patients not receiving RRT (4.3 % of BW) and on day 5 in AKI-RRT patients (7.9 % of BW). The main findings were: (1) the odds ratio (OR) for hospital mortality increased by 1.075 (95 % confidence interval 1.055-1.095) with every 1 % increase of MFO. When adjusting for severity of illness and AKI status, the OR changed to 1.044. This phenomenon was a continuum and independent of thresholds as previously reported. (2) Multivariate analysis confirmed that the speed of fluid accumulation was independently associated with ICU mortality. (3) Fluid accumulation increased significantly in the 3-day period prior to the diagnosis of AKI and peaked 3 days later. CONCLUSIONS In critically ill patients, the severity and speed of fluid accumulation are independent risk factors for ICU mortality. Fluid balance abnormality precedes and follows the diagnosis of AKI. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Garzotto F, Ostermann M, Martín-Langerwerf D, Sánchez-Sánchez M, Teng J, Robert R, et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit Care. 2016; 20(1):196 | es |
dc.identifier.doi | 10.1186/s13054-016-1355-9 | |
dc.identifier.essn | 1466-609X | |
dc.identifier.issn | 1364-8535 | |
dc.identifier.pmc | PMC4918119 | |
dc.identifier.pmid | 27334608 | |
dc.identifier.uri | http://hdl.handle.net/10668/2397 | |
dc.journal.title | Critical Care (London, England) | |
dc.language.iso | spa | |
dc.publisher | Biomed Central | es |
dc.relation.publisherversion | http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1355-9#Abs1 | es |
dc.rights.accessRights | open access | |
dc.subject | Fluid overload | es |
dc.subject | RRT | es |
dc.subject | AKI | es |
dc.subject | Critical illness | es |
dc.subject | ICU | es |
dc.subject | Estudios de seguimiento | es |
dc.subject | Mortalidad hospitalaria | es |
dc.subject | Humanos | es |
dc.subject | Unidades de cuidados intensivos | es |
dc.subject | Análisis multifactorial | es |
dc.subject | Cociente de probabilidades | es |
dc.subject | Tratamiento de reemplazo renal | es |
dc.subject | Factores de riesgo | es |
dc.subject | Sepsis | es |
dc.subject | Equilibrio hidroelectrolítico | es |
dc.subject | Lesión renal aguda | es |
dc.subject | Peso corporal | es |
dc.subject | Comorbilidad | es |
dc.subject | Intervalos de confianza | es |
dc.subject | Enfermedad crítica | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Renal Insufficiency::Acute Kidney Injury | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Physiological Phenomena::Physiological Processes::Growth and Development::Growth::Body Size::Body Weight | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Comorbidity | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Confidence Intervals | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Critical Illness | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies::Follow-Up Studies | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Mortality::Hospital Mortality | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Facilities, Manpower, and Services::Health Facilities::Hospital Units::Intensive Care Units | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Analysis of Variance::Multivariate Analysis | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Odds Ratio | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Renal Replacement Therapy | es |
dc.subject.mesh | Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Epidemiologic Factors::Causality::Risk Factors | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Sepsis | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Physiological Phenomena::Physiological Processes::Homeostasis::Water-Electrolyte Balance | es |
dc.title | The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. | es |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 3 of 3
Loading...
- Name:
- GarzottoF_TheDoseResponseMulticentre.pdf
- Size:
- 2.41 MB
- Format:
- Adobe Portable Document Format
- Description:
- Artículo publicado
No Thumbnail Available
- Name:
- GarzottoF_TheDoseResponse_AdditionalFile1.docx
- Size:
- 251.06 KB
- Format:
- Microsoft Word XML
- Description:
- File 1
No Thumbnail Available
- Name:
- GarzottoF_TheDoseResponse_AdditionalFile2.docx
- Size:
- 19.35 KB
- Format:
- Microsoft Word XML
- Description:
- File 2